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ABSTRACT Adult skeletal muscle fiber is a symplast multinuclear structure developed in ontogenesis by the fusion of 
the myoblasts (muscle progenitor cells). The nuclei of a muscle fiber (myonuclei) are those located at the periphery 
of fiber in the space between myofibrils and sarcolemma. In theory, a mass change in skeletal muscle during exercise 
or unloading may be associated with the altered myonuclear number, ratio of the transcription, and translation and 
proteolysis rates. Here we review the literature data related to the phenomenology and hypothetical mechanisms of 
the myonuclear number alterations during enhanced or reduced muscle contractile activity. In many cases (during 
severe muscle and systemic diseases and gravitational unloading), muscle atrophy is accompanied by a reduction in the 
amount of myonuclei. Such reduction is usually explained by the development of myonuclear apoptosis. A myonuclear 
number increase may be provided only by the satellite cell nuclei incorporation via cell fusion with the adjacent my-
ofiber. It is believed that it is these cells which supply fiber with additional nuclei, providing postnatal growth, work 
hypertrophy, and repair processes. Here we discuss the possible mechanisms controlling satellite cell proliferation 
during exercise, functional unloading, and passive stretch.
KEYWORDS skeletal muscle, myonuclei apoptosis, physical training, working hypertrophy, satellite cells, growth fac-
tors, gravitational unloading, muscle stretch.
ABBREVIATIONS IGF – insulin-like growth factor, AIF – apoptosis-inducing factor, GFP – green fluorescent protein, 
BrdU – 5-bromo-2-deoxyuridine, CD34, 45, 54 - clusters of differentiation, c-Met – HGF receptor, HGF – hepatocyte 
growth factor, FGF fibroblast growth factor, MMPs – matrix metalloproteinases, MGF – mechano-growth factor.
INTRODUCTION
Skeletal muscle is the most flexible structure in mamma-
lian organisms. High muscle activity and load often lead to 
an increase in the transverse size (thickness) of the muscle, 
myofibrils volume, and contractile properties (strength and 
power). The stable pattern of gene expression underlies such 
transformation.
A chronic decrease in the functional load on the postural 
muscles, primarily soleus, under a prolonged change in the 
action of gravity forces (bed rest, support elimination from 
all or only hind limbs, or weightlessness) – so-called gravita-
tional unloading – deeply transforms all the structural and 
functional muscle-tissue machinery [1–3]. One of the most 
important consequences of muscle transformation under hy-
pogravity is the decrease in the contractile properties (power 
and working capacity), stiffness of muscle and myofibers, and 
a significant decline in myofibril and nuclei number, as well 
as in fiber size (atrophy). It also leads to an overgrowth of the 
connective tissue and extracellular structures and a shifting 
of the phenotype of myosin heavy chains towards an increase 
in the expression of the fast isoforms of the myosin heavy 
chains. The data obtained in the last years showed that the 
gravity-dependent transformation of soleus fibers is based 
on a stable directional change in the expression of a number 
of genes and the generation of a new integral (the so-called 
atrophic) expression pattern.
Adult muscle fiber is a symplast ,a multinuclear struc-
ture, developed in ontogenesis by the fusion of myoblasts 
(muscle progenitor cells). Nuclei are located at the periphery 
of muscle fiber in the space between myofibrils and the cell 
membrane (sarcolemma). Muscles contain also the nuclei 
of fibroblasts, endothelial cells, and precursor cells (satel-
lite cells). Thus, in the literature, muscle fiber nuclei are 
usually called myonuclei. In theory, as a result of disuse or 
overload, the skeletal muscle mass can change, because of 
a change in the number of myonuclei or alterations in the 
rates of transcription, translation, and proteolysis. In this 
work we review data accumulated in the literature concern-
ing the phenomenology and possible mechanisms of changes 
in the quantity of muscle fiber nuclei during increased or 
decreased contractile activity.
The muscle fiber nuclei are postmitotic and cannot divide. 
Myonuclei quantity is extremely important, since it deter-
mines the content of DNA for gene transcription [4]. The 
interaction between the fiber size and myonuclei number 
was taken as the basis in the myonuclear domain concept of-
fered by Cheek et al. [5]. Myonuclear domain is the volume 
of muscle fiber cytoplasm regulated by the expression of the 
genes of one nucleus. The term “myonuclear domain” is quite 
convenient for describing the mechanisms of muscle plastic-
ity, though it is nominal, and the protein distribution inside 
muscle fiber depends on many variable parameters. A lot of 60 | ACTA NATURAE |  VOL. 2  № 2 (5)  2010
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studies have analyzed the cross-sectional area per one myo-
nucleus, instead of the domain.
To reveal the myonuclei, DNA-specific dyes are used. The 
main problem for researchers of the nuclear pool of muscle 
fiber face is that, in an analysis of the muscle transverse sec-
tions without special techniques, it is impossible to distin-
guish the nuclei located on different sides of the muscle fiber 
boundary. To solve this problem, different approaches are 
used; in particular, the double labeling of nuclei and specific 
proteins of the subsarcolemmal layer, such as dystrophin [6]. 
Many authors have analyzed the nuclear composition of the 
isolated muscle fiber [7, 8]. To study an isolated fiber, which 
is a volumetric structure, a confocal laser microscope should 
be used. This approach has evident advantages: all of the 
myofiber nuclei pool can be analyzed (not only the nuclei ob-
served at the cross section); also, the nuclei density distri-
bution along the muscle fiber and its elementary unit, sar-
comere, can be traced. However, the number of the fibers is 
limited in this case by 20–30 fibers per one biological sample.
Allen et al. have offered a hypothesis of myonuclear do-
main constancy during the size changes of the muscle fib-
ers (atrophy and hypertrophy) [4]. The authors showed that 
the myonuclear domain size remains stable during the acute 
stage of hypertrophy. A proportional increase in the myonu-
clei quantity and cytoplasm volume was observed on a model 
of functional hypertrophy caused by the removal of syner-
gistic muscles [9]. The same authors showed the variability of 
the myonuclear domain size during a chronic increase or de-
crease in loads in dogs [10] and under atrophy in rats [7]. Thus, 
the hypothesis of the myonuclear domain constancy turned 
out to be indefensible, and it has been further disproved in 
numerous studies of disuse and training [11–13, 8]. The myo-
nuclear domain has been found to change throughout an ani-
mal’s lifetime [14–16]. Recent studies by Italian authors have 
proved the possibility of hypertrophy development without 
new myonuclei incorporation; i.e., without a myonuclear do-
main increase under hypertrophy [11].
MYONUCLEAR NUMBER REDUCTION
In a number of cases (during severe muscle and systemic 
diseases and under gravitational unloading), muscle atrophy 
is accompanied by a decrease in the myonuclei number per 
myofiber, along with a corresponding development of apop-
totic processes in the myonuclei. Such a reduction in the nu-
clei number was observed in cosmonauts’ quadriceps [17] and 
rat soleus after space flight [10, 12], under simulated unload-
ing in rats using the so-called hindlimb suspension technique 
[18, 19], and during soleus immobilization. Myonuclei loss is 
most intensive in slow fibers [19]. Studies of single fibers have 
demonstrated a decrease in the myonuclear domain size un-
der disuse in rat soleus, but not in plantaris [12]. The myonu-
clear domain of rhesus monkeys also tends to decrease after 
14 days in space flight [20]. Wang et al. showed a reduction of 
the cross sectional area, myonuclei number (25%), and nu-
clear domain size of soleus fibers after 16 days of rat hindlimb 
suspension [21].
Myonuclear number reduction is explained by the nuclei 
apoptosis in muscle fibers. Apoptotic processes in muscle fib-
ers develop differently than those in other cell types. The 
changes in contractile activity lead to a weak manifestation 
of ultrastructural nuclei destruction. At the same time, DNA 
breaks in the nuclei are accompanied by a number of mito-
chondrial and extramitochondrial events which are supposed 
to be components of the interdependent signaling pathways, 
which cause the apoptotic processes.
Apoptotic nuclei have been observed in the muscle fibers 
of patients with Duchenne dystrophy (and in its biological 
model, mdx mice) [22], in fibers affected by chronic heart fail-
ure, the development of amyotrophic lateral sclerosis, and in 
some other cases. Myonuclei apoptosis was also observed after 
the application of a specific physical load (so-called eccentric 
exercise) [23]. In this case, muscle fiber strain develops when 
the fibers are stretched. Such muscle contraction causes nu-
merous destructive changes in the cytoskeletal proteins and 
sarcolemma. In 1997, Allen et al. first reported the presence 
of apoptotic nuclei during rat hindlimb suspension [18]. The 
maximum number of apoptotic nuclei was observed in the 
soleus fibers (according to the TUNEL staining, revealing the 
DNA breaks) in the 2nd day of soleus disuse [24]. 
The same data were obtained in experiments on mice, 
where the maximum apoptosis-inducing factor (AIF) and p53 
expression after 24 h of disuse were determined [25]. This was 
preceded by a marked increase in caspase-3 and caspase-8 
after 12 h of suspension. An increased concentration of Bcl-2 
was found as early as after 6 h of disuse. During hindlimb sus-
pension for over 24 h, the observed apoptotic manifestations 
decreased. Soleus immobilization revealed similar dynamics 
[24]. Seven days of reloading after hindlimb suspension were 
enough to eliminate apoptosis [26]. Some authors were unable 
to find caspase cascade activation in soleus under hindlimb 
unloading or spinal isolation [27], but they observed endonu-
clease G translocation to the nucleus. Endonuclease G is the 
mitochondrial enzyme degrading nuclear DNA. Recently, a 
group of authors suspended animals under decreased tem-
perature, which is supposed to slow down the mitochondria-
dependent processes. In this case, apoptotic nuclei and signifi-
cant caspase activation were also observed [28].
As was mentioned previously, a single exercise bout caused 
different apoptotic manifestations (DNA fragmentation, in-
creased caspases activity, etc.); however, regular physical 
training not only decreased such apoptosis manifestations, 
but it also had an antiapoptotic effect that eliminated the nu-
clear changes that take place when muscle activity is reduced 
[18].
Unlike the other cell structures, in a skeletal muscle fiber 
apoptosis of the individual nuclei does not lead to immediate 
fiber death, though pathological consequences develop.
Recently, the Bruusgaard group [29] cast doubt on the 
complex of described observations of nuclear losses and ap-
optosis during atrophy. The authors studied mice transfected 
with the GFP-encoding plasmid. GFP was localized in the 
myonuclei, the quantity of which was analyzed under pro-
longed (14 days) denervation and disuse of extensor digito-
rum longus (caused by antagonists’ tenotomy). The authors 
observed a significant decrease in the cross-sectional area of 
the muscle fibers, but no myonuclei decline. Fixed apoptotic 
changes were found in the satellite and connective tissue cells 
only; they were not revealed in muscle fibers. The same re-
sults were observed during the detraining of the Japanese 
quail wing: all the nuclei with apoptosis features were labeled REVIEWS
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with bromdeoxyuridine (BrdU), the DNA synthesis indica-
tor, which revealed the satellite cell nuclei [30]. At the same 
time, the conclusion made by Bruusgaard and Gundersen [29] 
was based on the denervation experiment and a study of the 
blockade of nerve impulse conduction to muscles predomi-
nantly with the fast fibers (those fibers undergo apoptosis 
less; see above). The authors dispelled any doubt about the 
data testifying to apoptosis and myonuclei number reduction 
using an animal microgravity model of antiorthostatic hind-
limb suspension (and, consequently, the results of analogous 
experiments on volunteers; see above). They assumed that, in 
this case, systemic manifestations of gravitational unloading 
favored myonuclei apoptosis. Unfortunately, this hypothesis 
has no experimental support.
An increase in myonuclei in adult muscle fiber was ob-
served during a power exercise, experimental working 
hypertrophy (during synergistic muscles dissection), and 
postatrophic reloading [26, 31–33]. The new nuclei in a fiber 
can be provided only by the fusion of satellite cells with the 
muscle fiber. The satellite cells are supposed to provide new 
nuclei for the muscle fiber during the postnatal period and 
for the local regeneration of the injured muscle fibers [34].
PRECURSOR CELLS IN SKELETAL MUSCLE. 
THE MARKERS OF THE MYOSATELLITE CELLS.
Satellite cells in a skeletal muscle are small mononucle-
ate resting cells (remaining in the Go phase of the cell cycle) 
which proliferate and fuse with muscle fibers when activated, 
being an essential source of myonuclei during postembryonic 
development under tissue hypertrophy and recovery [12]. 
They can also fuse with each other, forming new muscle fib-
ers [16]. Satellites may be myoblasts resting in the muscle tis-
sue. According to another opinion, satellites are also believed 
to derive from some endothelial precursors associated with 
the embryonic vascular system. They can rest in the skeletal 
muscle interstitial space and express CD 34 [35]. However, 
skeletal muscle myogenic precursors are more numerous than 
satellite cells, because of the migration or recruitment of the 
undifferentiated stem cells from other sources. The precursor 
cell population from skeletal muscle was shown to originate 
from virgin mesenchymal stem cells of bone marrow and dif-
fers from satellite cells. Unlike satellites, precursor cells of 
the side population express Sca-1 (stem cell antigen-1) and 
CD-45. Evidently, they take part in injured or transplanted 
muscle regeneration and potentially form myocytes and myo-
satellite cells [36, 37]. Myosatellites can be identified in a mus-
cle by their location (between the sarcolemma and fiber basal 
lamina) and by the immunohistochemical identification of 
different proteins expressed by these cells at different stag-
es of their cell cycles. Desmin, myf5, and MyoD were found 
in the activated proliferating satellite cells, which normally 
express the regulatory muscle factors, such as Pax-7 and c-
Met. Myogenin and MRF4 synthesis is characteristic of the 
final stage of differentiation [38]. c-Met, the HGF receptor, 
is expressed in skeletal muscle not only by satellites, but also 
by other myogenic precursor cells. Like resting cells, active 
and proliferating satellite cells usually synthesize such cell 
adhesion molecules as m-cadherin (Mcad) and NCAM (CD 56, 
Leu-19, neural cell adhesion molecule), which are located in 
the narrow space between the satellite cell and muscle fiber. 
NCAM is expressed in the activated satellite cells (myoblasts), 
in myotubes during muscle regeneration, and in neuromuscu-
lar junctions. Recent data showed that NCAM is the earliest 
marker of committed myoblasts; i.e., it determins their uni-
vocal transition from the proliferation to the differentiation 
phase [39].
The key molecule of the myogenic morphogenesis is Mcad. 
Using the combined labeling of Mcad, NCAM, laminin, de-
smin, and cell nuclei, Irintchev et al. [40] demonstrated that 
Mcad occurs in the satellite cells and myoblasts of normal and 
regenerating muscle. Simultaneous staining of the regenerat-
ing muscle with Mcad and BrdU led the authors to conclude 
that Mcad is expressed predominantly in mitotically inactive 
(resting) satellite cells. The myoblast fusion suppressed Mcad 
expression. NCAM and Mcad simultaneous expression is of-
ten observed in the muscles with an innervation failure [40]. 
As was shown later [41], skeletal muscle hypertrophy caused 
by overloading and the number of myosatellites expressing 
Mcad at the early stages of stimulus application increased, 
while at the later stages the number of cells positively stained 
against Mcad and NCAM rose. Thus, the Mcad staining was 
found in the resting myosatellites similarly as in the prolifera-
tion and differentiation stages. 
MYOSATELLITE CELLS UNDER GRAVITATIONAL UNLOADING
Three days of hindlimb unloading lead to an irreversible 
transformation in the muscles of young rats. Therefore, the 
satellite cell number and their proliferative potential (ac-
cording to the BrdU incorporation data) declined in soleus 
in the same way as in extensor digitorum longus. In this case, 
the program of muscle fiber development in growing animals 
can change irreversibly, leading to a failure of the myonuclei 
number increase even after reloading [42, 43]. Satellite cell mi-
totic activity decreased after 24 h of disuse and completely 
deceased 3–5 days later. The most pronounced decline was 
observed in soleus. Morphological atrophy features were re-
vealed 48 h later [43]. The increase in the proliferative process-
es in mice gastrocnemius appeared after one week of hindlimb 
suspension [44]. The quantity of the resting and mitotically ac-
tive satellites in muscle fiber fell by 57% when compared to 
the control group [29]. In the other work by the same authors, 
3 months of unloading caused no decrease in the satellite cell 
quantity or muscle fiber length in young animals, but it led 
to an apoptosis-independent decrease in the satellite cell and 
myonuclei contents and a decrease in the satellite mitotic ac-
tivity [45]. However, Ferreira et al. [44] observed unexpected 
proliferation reinforcement in mice gastrocnemius after one 
week of suspension.
POSSIBLE WAYS OF ACTIVATING MYOSATELLITES 
Myosatellites are supposed to rest when skeletal muscle is not 
active. Their activation provides muscle mass maintenance, 
hypertrophy development, or the recovery of injured muscle. 
Myosatellite activation can also be caused by strengthening 
exercise [46, 47].
A significant increase in the total number of satellites was 
shown on several models of compensatory hypertrophy in 
animals, after eccentric exercise in humans [13, 48], and dur-
ing muscle stretching [49]. Physical activity, such as resistive 
exercise or muscle functional overload (chronic stretch, syn-62 | ACTA NATURAE |  VOL. 2  № 2 (5)  2010
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ergistic muscle removal, and tenotomy), injures muscle tissue 
[50], stimulating muscle regeneration. Muscle damage causes 
an inflammatory response. Therefore, in the injured area, the 
number of neutrophils and macrophages increases. Then, the 
inflammatory infiltrate is released by immune cells, or the in-
jured fibers release the growth factors regulating the prolif-
eration and differentiation of myosatellites. Cytokines (IL-4, 
IL-6, IL-15, TNF-α etc.) were shown to affect the satellite cells 
in vitro and during the regeneration of injured muscle [51]. The 
role of the fibroblast growth factor (FGF) in myosatellite acti-
vation has been shown previously [52]. The hepatocyte growth 
factor (HGF) is supposed to be the key regulator of satellite 
cells activity during regeneration [18, 53] (Fig. 1). HGF was es-
tablished to stimulate satellite cell activation in culture and in 
vivo during muscle stretch. HGF release is induced by nitric 
oxide (NO) synthesis, and it is regulated by matrix metallopro-
teinases (MMPs) [55]. HGF affects a satellite through its bind-
ing to the c-met receptor, stimulating further the signaling 
cascade, including the PI3K-Akt pathway, which stimulates 
cell survival and protection against apoptosis. The results of 
numerous experiments have shown the important role of the 
insulin-like growth factor in muscle hypertrophy develop-
ment. In in vivo studies on animals, data were obtained dem-
onstrating the role of an insulin-like growth factor (IGF) in 
the growth processes mediated by myosatellite activity [56, 
57]. IGF can stimulate myosatellite proliferation and differ-
entiation in culture [58]. Myosatellite cells of mice with IGF-1 
gene overexpression possess increased proliferative potential, 
which can be due to the activation of a PI3K-Akt signaling 
pathway and the decline of the blocker of the cyclin-depend-
ent kinase-2 [59], which is a result of FOXO transcription fac-
tor inhibition [57]. This is why the IGF-1-activated signaling 
pathways, which stimulate translation, are also supposed to 
be activated in myosatellite cells [60]. However, IGF-1EA (the 
growth factor form expressed in liver cells and skeletal mus-
cle fibers which releases into the blood flow) is not the only 
IGF-1 gene product. 
Physical training or mechanical muscle damage results in 
IGF-1 gene splicing, leading to the appearance of a splice-
variant called the mechano-growth factor (MGF) after 1–2 
days. During splicing, the translational frame shift occurs, 
resulting in a C-terminal sequence change. This leads to the 
appearance of the so-called E-domain, which differs from 
the other IGF-1 splice-variant sequences [61]. This unique 
C-terminal peptide functions as an autocrine growth factor 
with a short half-life. One of the functions of the peptide is to 
increase the precursor-cell pool in skeletal muscle (satellite 
cells) by initiating stem-cell proliferation, however, without 
myogenic differentiation. After initial splicing leading to MGF 
formation, the IGF-1 gene product undergoes further splic-
ing, generating the IGF-1EA isoform. IGF-1EA is supposed to 
stimulate myosatellite differentiation and fusion with muscle 
fiber [38, 49, 62]. However, according to Wozniak et al. [38], 
only HGF and NO have been proven to activate resting myo-
satellites. IGF, FGF, and other growth factors were shown 
to effectively stimulate proliferation and growth following 
satellite activation. Some other growth factors (in particular, 
FGF) can also activate satellite cell proliferation [52]. Myosat-
ellite cell activation can be suppressed by myostatin, which 
is supposed to maintain myosatellites at rest [63]. However, 
the mechanisms inducing satellite cell activation, prolifera-
tion, and their fusion with injured or growing muscle fibers 
remain poorly understood.
THE ROLE OF PRECURSOR CELLS IN MUSCLE GROWTH 
Satellite cells possess high proliferative potential and are sup-
posed to be important for skeletal muscle regeneration and 
hypertrophy. Different stimuli, such as functional overload 
during synergist removal, testosterone, clenbuterol, muscle 
stretch, and exercise can activate the satellites, stimulate 
their entry to the cell cycle and their proliferation in both 
fast and slow muscles. An increase in satellite prolifera-
tion was observed in the first days after stimulus applica-
tion. Cramery et al. [46] and Kadi et al. [13, 31] showed that 
a series of intensive exercises stimulated an increase in the 
number of cells expressing NCAM. However, this and other 
studies did not show proliferating cells fusing with muscle 
fibers. The question of whether myosatellite nuclei incor-
poration into the fiber is necessary for muscle growth or 
mass maintenance remains unanswered. Different points of 
view exist. Many authors deny the necessity of incorporat-
ing myosatellite nuclei for muscle hypertrophy development 
[64], which has been proven by numerous studies with β2-
adrenoceptor agonists application, leading to muscle hyper-
tropy without an increase in DNA or the myonuclear num-
ber. According to Kadi et al. [13], muscle fiber size can change 
moderately without the incorporation of new myonuclei. 
As was shown earlier, the myonuclear number is not normally 
the determining factor for muscle fiber size; the myonuclear 
domain size varies during an animal’s lifetime [16] and is un-
stable under muscle atrophy [65]. Despite the lack of dividing 


























Fig. 1. The hypothetical role of IGF-1 and MGF in satellite cell 
physiology. Modified scheme of Olguin and Olwin, 2004 [54].REVIEWS
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observed hypertrophy of the stretched slow anterior latis-
simus dorsi of the Japanese quail. Dupont-Versteegden et al. 
[66] showed that in spinalized animals, after myosatellite acti-
vation (during resistive exercise), the latter did not fuse with 
the muscle fibers. Thus, training did not promote the mainte-
nance of the myonuclear number in the soleus of spinal ani-
mals. The number of activated myosatellites was higher than 
that of divided ones. The physiological role of activation of 
such a huge number of myosatellites without their incorpora-
tion into the growing muscle fibers is unclear. Recently, Ital-
ian researchers showed that proteinkinase B activation for 3 
weeks caused muscle hypertrophy and a doubling of muscle 
weight, which was not accompanied by satellite activation or 
the incorporation of new nuclei [11].
The possibility of muscle fiber growth without incorpora-
tion of satellite cells, which is one of the ways protein syn-
thesis intensifies, can be due to an increase in DNA matrices 
because of the incorporation of myosatellite nuclei into the 
fiber. The supporters of the concept of myonuclear domain 
constancy theorize that the initial stages of muscle growth 
are linked with transcription and translation intensification 
until the myonuclear domain reaches a definite threshold. 
However, it was established that moderate hypertrophy in 
human muscles can happen without additional genetic ma-
terial [13]; from the point of view of the concept mentioned 
above, this can be explained by the existence of a hypertro-
phy threshold sensitive to the new nuclei incorporation. Thus, 
at later stages, the incorporation of new myosatellite nuclei 
is obligatory for maintaining muscle fiber hypertrophy and 
the nuclear domain size [9, 33, 64]. The necessity of myosatel-
lites for muscle hypertrophy development was first shown by 
Rosenblatt et al. [9], who observed a decrease in hypertrophy 
under functional overload after averting satellite prolifera-
tion by γ-irradiation. The authors determined that satellite 
cell death under the irradiation and obviation of their nuclei’s 
incorporation into muscle fibers can completely neutralize the 
hypertrophy of rat extensor digitorum longus, soleus, and 
plantaris caused by the removal of synergistic muscles and 
physical training [67]. Mitchell and Pavlath [33] showed that, 
after rat hindlimb suspension and irradiation, the preven-
tion of myosatellite proliferation muscle recovery was normal 
only at the stage where new myonuclei were not necessary, 
but then the process slowed. Kawano et al. [45] showed that, 
during 3 months of reloading young animals suspended for 
3 months, the fiber cross-sectional area did not differ from 
that of the control animals, while the satellites and myonu-
clei number increased. The authors concluded that satellite 
cells were important for soleus growth processes [45]. As was 
shown earlier, the proliferation, differentiation, and fusion 
of myosatellites with muscle fibers are induced by growth 
factor IGF-1 [68]. In the muscle fiber culture, IGF-1 caused 
myosatellite fusion resulting in hypertrophy [62]. The IGF-
1-stimulated hypertrophy was accompanied by an increase 
in DNA content in the muscle fibers and the appearance of 
new myonuclei [69]. The irradiation was shown to decrease 
the hypertrophy of the extensor digitorum longus caused by 
the intramuscular IGF-1 incorporation twice, inasmuch as 
in hypertropy induced by the incorporation of myosatellites 
nuclei into the muscle fibers [70]. These data showed that 
the loading-stimulated increase in the IGF-1 level can cause 
hypertrophy, particularly due to the stimulation of myosatel-
lites proliferation and fusion with the maternal fiber.
Data has appeared recently showing that the myosatellite 
nuclei can incorporate into a fiber under low-intensity chron-
ic training: during low-frequency chronic electro stimula-
tion and voluntary animal activity (“voluntary wheel”) [71]. 
Such a regime of contractile activity usually does not lead to 
working hypertrophy. However, myosin phenotype actively 
shifts to the slow direction. As was shown previously [72], an 
increase in the slow fiber number during the slow-frequency 
stimulation of rat fast muscles cannot be explained by the 
change in the myosin isoforms expression inside a fiber. The 
suppression of myosatellites multiplication prevented by ir-
radiation was established recently to prevent the transforma-
tion of fibers to the slow type during low-frequency chronic 
stimulation [73]. It is of interest that pharmacological stimu-
lation of PPARβ (peroxisome proliferator-activated receptor 
β) is one of the components of the signaling system switching 
myosin isoform expression to the slow type in the myonuclei 
and favors myosatellite fusion with a muscle fiber [74].
Thus, the incorporation of myosatellite nuclei (evidently 
with a slow pattern of myosin isoform expression) into muscle 
fiber during prolonged low-frequency stimulation leads to 
myosin phenotype adaptive changes in the skeletal muscle.
MYOSATELLITE CELLS OF SKELETAL MUSCLE DURING 
STRETCH AND STRETCH COMBINED WITH DISUSE
Gravitational unloading is a particular type of muscle con-
tractile activity reduction. A sharp decrease in the electric 
activity of soleus (to the zero level) is observed, as a rule, im-
mediately after support elimination and continues for 2–3 
days of disuse. Then electric activity begins its restoration 
slowly and reaches the control level by the 14th day of real or 
simulated microgravity [75]. However, gradually increased 
muscle activity does not prevent muscle atrophy develop-
ment. Evidently, the decreased contractile activity has an 
affect alongside with the the significantly declined (to zero 
under microgravity) resistance to muscle contraction ( weight 
bearing), which has a significant influence on atrophy devel-
opment [76]. One approach to studying this factor is chronic or 
repeated passive stretch of the muscle. This stretch compen-
sates for the lack of gravity loading and certainly prevents 
the development of muscle regeneration [77].
The interrelation between stretch and myosatellite acti-
vation in culture was demonstrated in the experiments con-
ducted by Tatsumi et al. [78]. Resting satellite cells under pe-
riodic stretch activated and entered the cell cycle, probably 
being stimulated by HGF synthesis in the stretched cells. The 
same authors showed that, during a short stretch (1 h) com-
bined with the hindlimb suspension of rats, mechanical stretch 
caused nitric oxide (NO) synthesis. The latter induced HGF 
linked with the muscle fiber surface. HGF binds the c-Met-
receptor of the myosatellite cells, leading to their activation. 
On the other hand, data exist indicating that, during compen-
satory hypertrophy caused by the synergistic-muscle removal, 
myonuclei activation can occur independently from the NOS 
inhibitor [79]. In the model of Wozniak et al. [38], isolated mus-
cle stretch, such as during a single fibers stretch, activated 
myosatellites, which were determined by BrdU incorporation 
into the dividing cell nuclei. In our study, 3 days of simulated 64 | ACTA NATURAE |  VOL. 2  № 2 (5)  2010
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gravitational unloading (hindlimb suspension model) caused no 
change in the satellite cells expressing m-cadherin in rat sole-
us, while 7 and 14 days of disuse caused a 30 and 50% decrease 
in the number of myosatellites, correspondingly, as compared 
to the control. Passive soleus stretch combined with gravita-
tional unloading made it possible to maintain the amount of 
satellites 30% higher than in the control at the 3rd and 7th days 
of disuse, and at the control level until the 14th day of unload-
ing (Fig. 2). We surmised that, after the elimination of the pro-
liferative potential of precursor cells by γ-irradiation, muscle 
fibers partially lose their ability to maintain fiber size during 
stretch combined with disuse. A study of local irradiation of a 
rat shin with a dosage of 2500 rad followed by hindlimb sus-
pension or suspension combined with stretch showed that ir-
radiation did not influence the countermeasure effect of pas-
sive stretch (atrophy prevention, fibers transformation, and 
myonuclei number decrease), which was observed under sus-
pension [80]. Recent in vivo experiments demonstrated that 
L-arginine (NO donor) administration under disuse decreased 
muscle atrophy and maintained the number of myonuclei and 
myosatellites at the control level. Moreover, NO-synthetase 
inhibitor, L-NAME, significantly decreased myosatellite pro-
liferation during stretch combined with animal hindlimb sus-
pension. Thus, one can assume that, in the studied model, NO 
significantly influences myosatellites proliferation. However, 
an administration of NO-synthetase blocker did not affect the 
efficiency of maintaining muscle mass during the stretch (see 
the significance of myosatellite proliferation during hypertro-
phy above) [81].
Myotube stretch in culture leads to the release of other 
endocrine factors, including IGF. The studies conducted by 
the Goldspink laboratory [49, 61] showed that, during stretch 
combined with the electro stimulation of the tibialis ante-
rior and during mechanical injury, myosatellite activation 
occurred along with IGF-1 mRNA expression. The authors 
linked the resting myosatellite activation and proliferation 
during muscle stretch to the expression of MGF (the maximal 
expression of the splice-variant MGF was observed in the 
first 4 days after the stretch), while their differentiation and 
fusion with the muscle fibers depended on the subsequent 
IGF-1Ea (5–12 days after applying the stretch) [49].
Interestingly, in our studies IGF-1 expression stimulation 
was observed only on the 7th day of stretch combined with 
gravitational unloading, while the myosatellite-cell number 
increased on the 3rd day. The proliferation of these cells dur-
ing stretch combined with disuse can probably be explained 
by the earlier MGF expression. Further studies should shed 
more light on the question.
Thus, we can assume that myosatellite proliferation during 
stretch combined with gravitational unloading, which is stim-
ulated by different mechanisms, is unnecessary for prevent-
ing the atrophy of muscle fibers. The myonuclear number 
is probably maintained in this case due to the antiapoptotic 
effect of the stretch. However, the concomitant myosatellite 
activation prevents a decrease in the muscle-regeneration 
potential.
Therefore, in this review we have discussed one of the 
most controversial issues surrounding skeletal muscle plas-
ticity: the effect of the contractile activity on the myonuclear 
pool. The perspectives of pharmacological and gene-thera-
peutic regulation of myonuclei apoptosis and myosatellite ac-
tivity are also of importance. NO donors and the recombinant 
analogues of the growth factors as countermeasures to the 
atrophy changes in skeletal muscle during posthypokinetic 
recovery and the rehabilitation of injured athletes need fur-
ther study. 
This work was supported by RFBR grants 07-04-00763, 
08-04-01557, 10-04-00504. The authors are grateful to 
Professor G. Goldspink (Royal Free and University College, 
London) for helpful comments in our discussions of the main 
statements in this review. 
Fig. 2. Satellite 
cells in rat m.soleus 
transverse section. 
M-cadherin stain-
ing. (1) “Hindlimb 
suspension 3 
days,” (2) “Hind-
limb suspension + 
stretch 3 days,” 
(3) “Hindlimb sus-
pension 7 days”, 
(4) “Hindlimb sus-
pension +  stretch 
7 days”, (5) “Hind-
limb suspension 14 
days”, (6) “Hind-
limb suspension + 
stretch 14 days”, 
(7) Control. 
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